Objectives

After participating in this educational activity, attendees should be able to:

1|Recall the context of bi-specific antibodies within the evolving landscape of cancer therapy
2|Explain bi-specific antibody pharmacodynamic and safety profiles
3|Utilize national and Baystate Health resources to identify and manage common bi-specific antibody toxicities
 
Presenter(s): 
Matthew Murphy, PharmD, BCOP
Clinical Pharmacy Specialist, Oncology
Baystate Medical Center
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Matthew Murphy, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
06/30/2025 - 2:00pm to 3:00pm EDT
Add to calendar: 
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours
Please login or register to take this course.